Browsing Category

Dr. Paul Lohmann

Biocompatible hydroxy double salt tablet formulations

Generally, commercial extended release tablets are core-based, which can cause problems for certain patients if they split them prior to ingestion. There is a need to develop non-core-based extended release tablets. We have previously reported the synthesis of two new biocompatible hydroxy double…
Read More...